188Re(V)-DMSA revisited: Preparation and biodistribution of a potential radiotherapeutic agent with low kidney uptake

E. Dadachova, J. Chapman

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Methods of preparation and biodistribution in mice of tin-free 99Tc(m)(V)-DMSA and 188Re(V)-DMSA, a potential matching pair of radiopharmaceuticals for diagnosis and therapy of certain cancers, are described. Preparation of tin-free 188Re(V)-DMSA (I) is based on reduction with either SO2-releasing compounds like Na2S2O4 (30 mg Na22SO4, 10 mg DMSA, 1 mg L-ascorbic acid, 37°C, 60 min incubation), Na2S2O5 (as before, 70°C, 15 min incubation), or HBr (0.2 ml 48% HBr, 0.2 ml 7 M HC1, 10 mg DMSA, 1 mg L-ascorbic acid, 70°C, 60 min incubation). I exhibits significantly lower kidney uptake than tin-containing 188Re(V)-DMSA (II) (2-3% and 49% injected dose per gram organ, 1 h post-injection, respectively). HPLC profiles of I and II are similar DMSA excess in tin-free 188Re(V)-DMSA is not responsible for the low kidney uptake of I. High kidney uptake of II is explained by formation of a mixed 188Re(V)Sn-DMSA complex in vivo. Age-linked bone uptake in mice dependent on the maturation of the bone is demonstrated for both I and II.

Original languageEnglish (US)
Pages (from-to)173-181
Number of pages9
JournalNuclear Medicine Communications
Volume19
Issue number2
StatePublished - 1998
Externally publishedYes

Fingerprint

Succimer
Kidney
Tin
Ascorbic Acid
Bone and Bones
Radiopharmaceuticals
High Pressure Liquid Chromatography

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

188Re(V)-DMSA revisited : Preparation and biodistribution of a potential radiotherapeutic agent with low kidney uptake. / Dadachova, E.; Chapman, J.

In: Nuclear Medicine Communications, Vol. 19, No. 2, 1998, p. 173-181.

Research output: Contribution to journalArticle

@article{a90e8f780e5f469cb6cc7cf79d5485e6,
title = "188Re(V)-DMSA revisited: Preparation and biodistribution of a potential radiotherapeutic agent with low kidney uptake",
abstract = "Methods of preparation and biodistribution in mice of tin-free 99Tc(m)(V)-DMSA and 188Re(V)-DMSA, a potential matching pair of radiopharmaceuticals for diagnosis and therapy of certain cancers, are described. Preparation of tin-free 188Re(V)-DMSA (I) is based on reduction with either SO2-releasing compounds like Na2S2O4 (30 mg Na22SO4, 10 mg DMSA, 1 mg L-ascorbic acid, 37°C, 60 min incubation), Na2S2O5 (as before, 70°C, 15 min incubation), or HBr (0.2 ml 48{\%} HBr, 0.2 ml 7 M HC1, 10 mg DMSA, 1 mg L-ascorbic acid, 70°C, 60 min incubation). I exhibits significantly lower kidney uptake than tin-containing 188Re(V)-DMSA (II) (2-3{\%} and 49{\%} injected dose per gram organ, 1 h post-injection, respectively). HPLC profiles of I and II are similar DMSA excess in tin-free 188Re(V)-DMSA is not responsible for the low kidney uptake of I. High kidney uptake of II is explained by formation of a mixed 188Re(V)Sn-DMSA complex in vivo. Age-linked bone uptake in mice dependent on the maturation of the bone is demonstrated for both I and II.",
author = "E. Dadachova and J. Chapman",
year = "1998",
language = "English (US)",
volume = "19",
pages = "173--181",
journal = "Nuclear Medicine Communications",
issn = "0143-3636",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - 188Re(V)-DMSA revisited

T2 - Preparation and biodistribution of a potential radiotherapeutic agent with low kidney uptake

AU - Dadachova, E.

AU - Chapman, J.

PY - 1998

Y1 - 1998

N2 - Methods of preparation and biodistribution in mice of tin-free 99Tc(m)(V)-DMSA and 188Re(V)-DMSA, a potential matching pair of radiopharmaceuticals for diagnosis and therapy of certain cancers, are described. Preparation of tin-free 188Re(V)-DMSA (I) is based on reduction with either SO2-releasing compounds like Na2S2O4 (30 mg Na22SO4, 10 mg DMSA, 1 mg L-ascorbic acid, 37°C, 60 min incubation), Na2S2O5 (as before, 70°C, 15 min incubation), or HBr (0.2 ml 48% HBr, 0.2 ml 7 M HC1, 10 mg DMSA, 1 mg L-ascorbic acid, 70°C, 60 min incubation). I exhibits significantly lower kidney uptake than tin-containing 188Re(V)-DMSA (II) (2-3% and 49% injected dose per gram organ, 1 h post-injection, respectively). HPLC profiles of I and II are similar DMSA excess in tin-free 188Re(V)-DMSA is not responsible for the low kidney uptake of I. High kidney uptake of II is explained by formation of a mixed 188Re(V)Sn-DMSA complex in vivo. Age-linked bone uptake in mice dependent on the maturation of the bone is demonstrated for both I and II.

AB - Methods of preparation and biodistribution in mice of tin-free 99Tc(m)(V)-DMSA and 188Re(V)-DMSA, a potential matching pair of radiopharmaceuticals for diagnosis and therapy of certain cancers, are described. Preparation of tin-free 188Re(V)-DMSA (I) is based on reduction with either SO2-releasing compounds like Na2S2O4 (30 mg Na22SO4, 10 mg DMSA, 1 mg L-ascorbic acid, 37°C, 60 min incubation), Na2S2O5 (as before, 70°C, 15 min incubation), or HBr (0.2 ml 48% HBr, 0.2 ml 7 M HC1, 10 mg DMSA, 1 mg L-ascorbic acid, 70°C, 60 min incubation). I exhibits significantly lower kidney uptake than tin-containing 188Re(V)-DMSA (II) (2-3% and 49% injected dose per gram organ, 1 h post-injection, respectively). HPLC profiles of I and II are similar DMSA excess in tin-free 188Re(V)-DMSA is not responsible for the low kidney uptake of I. High kidney uptake of II is explained by formation of a mixed 188Re(V)Sn-DMSA complex in vivo. Age-linked bone uptake in mice dependent on the maturation of the bone is demonstrated for both I and II.

UR - http://www.scopus.com/inward/record.url?scp=0031594316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031594316&partnerID=8YFLogxK

M3 - Article

C2 - 9548202

AN - SCOPUS:0031594316

VL - 19

SP - 173

EP - 181

JO - Nuclear Medicine Communications

JF - Nuclear Medicine Communications

SN - 0143-3636

IS - 2

ER -